Astellas Pharma (4503.T) Return on Equity (ROE)

Price: $1477.5
Market Cap: $2.64T
Avg Volume: 6.30M
Country: JP
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.157
52W Range: $1415-1835
Website: Astellas Pharma

Return on Equity (ROE) Summary

Astellas Pharma's ROE measures the return generated on shareholders' equity:

  • Annual: 1.07%
  • Quarterly: -6.54%
  • TTM: -3.65%

What is Return on Equity (ROE)?

Return on Equity measures a company's ability to generate profits from its shareholders' equity. It indicates how effectively the management is using the company’s assets to create profits. A higher ROE generally reflects well on the company’s management and its ability to generate profits without needing as much capital.

Related Metrics

Other important metrics to assess Astellas Pharma's profitability include:

  • ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
    • Annual: 3.09%
    • Quarterly: -3.65%
    • TTM: 0.98%
  • ROA (Return on Assets) - measures the return generated on the company's assets:
    • Annual: 0.48%
    • Quarterly: -2.83%
    • TTM: -1.66%
  • Profit Margin - indicates the profitability of the company relative to its revenue:
    • Annual: 1.06%
    • Quarterly: -18.87%
    • TTM: -3.07%

These metrics provide insights into Astellas Pharma's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual ROE

1.07%

Quarterly ROE

-6.54%

TTM ROE

-3.65%

Astellas Pharma Historical ROE
17.66%17.66%14.13%14.13%10.60%10.60%7.07%7.07%3.53%3.53%0.00%0.00%ROE201620162017201720182018201920192020202020212021202220222023202320242024
Historical ROIC
15.55%15.55%12.44%12.44%9.33%9.33%6.22%6.22%3.11%3.11%0.00%0.00%ROIC201620162017201720182018201920192020202020212021202220222023202320242024
Historical ROA
12.01%12.01%9.61%9.61%7.21%7.21%4.80%4.80%2.40%2.40%0.00%0.00%ROA201620162017201720182018201920192020202020212021202220222023202320242024

Astellas Pharma Historical Profitability Metrics

The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.

Year ROE ROIC ROA Profit Margin
2024 1.07% 3.09% 0.48% 1.06%
2023 6.55% 5.50% 4.02% 6.50%
2022 8.50% 7.49% 5.32% 9.57%
2021 8.70% 6.71% 5.30% 9.65%
2020 15.16% 10.43% 8.43% 15.02%
2019 17.66% 15.55% 11.71% 17.01%
2018 12.98% 11.21% 8.86% 12.66%
2017 17.20% 14.25% 12.01% 16.67%
2016 15.38% 13.29% 10.76% 14.11%
2015 10.31% 9.69% 7.57% 10.89%

Related Metrics

Explore detailed financial metrics and analysis for 4503.T.